HK1086725A1 - Antioxidative compositions - Google Patents
Antioxidative compositionsInfo
- Publication number
- HK1086725A1 HK1086725A1 HK06106781A HK06106781A HK1086725A1 HK 1086725 A1 HK1086725 A1 HK 1086725A1 HK 06106781 A HK06106781 A HK 06106781A HK 06106781 A HK06106781 A HK 06106781A HK 1086725 A1 HK1086725 A1 HK 1086725A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vitamin
- antioxidative compositions
- antioxidative
- compositions
- epicatechin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003078 antioxidant effect Effects 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 abstract 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 abstract 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 abstract 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 abstract 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 abstract 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003537 Vitamin B3 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 abstract 1
- 235000012734 epicatechin Nutrition 0.000 abstract 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 abstract 1
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 235000005875 quercetin Nutrition 0.000 abstract 1
- 229960001285 quercetin Drugs 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Non-Alcoholic Beverages (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Paper (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Insulating Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42098602P | 2002-10-23 | 2002-10-23 | |
| US10/302,544 US6821536B2 (en) | 2002-11-22 | 2002-11-22 | Antioxidative compositions |
| PCT/US2003/032552 WO2004037015A1 (fr) | 2002-10-23 | 2003-10-14 | Compositions antioxydantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1086725A1 true HK1086725A1 (en) | 2006-09-29 |
Family
ID=32658824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06106781A HK1086725A1 (en) | 2002-10-23 | 2006-06-14 | Antioxidative compositions |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP1562447B1 (fr) |
| JP (3) | JP2006507283A (fr) |
| KR (2) | KR101186898B1 (fr) |
| AT (2) | ATE416629T1 (fr) |
| AU (2) | AU2003282829B2 (fr) |
| CA (2) | CA2503363C (fr) |
| DE (2) | DE60325265D1 (fr) |
| DK (2) | DK1562447T3 (fr) |
| ES (1) | ES2322577T3 (fr) |
| HK (1) | HK1086725A1 (fr) |
| NZ (1) | NZ540165A (fr) |
| PT (2) | PT1562447E (fr) |
| TW (2) | TWI337066B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2322577T3 (es) * | 2002-10-23 | 2009-06-23 | Quercegen Holdings Llc | Composiciones antioxidantes. |
| KR101154616B1 (ko) * | 2004-12-31 | 2012-06-08 | (주)아모레퍼시픽 | 캄페롤 및 퀘르세틴을 함유하는 히알루론산 생성 촉진용조성물 |
| JP4601570B2 (ja) * | 2006-03-20 | 2010-12-22 | 株式会社ロッテ | 抗酸化剤及びその製造方法並びに該抗酸化剤を含有する飲食品 |
| EP2040708B1 (fr) * | 2006-07-17 | 2018-03-14 | Thomas Christian Lines | Compositions contenant de la quercétine |
| JP5399864B2 (ja) * | 2008-11-10 | 2014-01-29 | 花王株式会社 | 精製茶抽出物 |
| EP2440206B1 (fr) * | 2009-06-11 | 2018-07-18 | DSM IP Assets B.V. | Trigonelline en tant que stimulant musculaire |
| JP5688234B2 (ja) * | 2010-03-12 | 2015-03-25 | 株式会社ヤマノホールディングス | Ｌ‐アスコルビン酸含有粉の製造方法 |
| JP2013542924A (ja) * | 2010-09-17 | 2013-11-28 | ストークリー−ヴァン キャンプ インコーポレイテッド | 血中乳酸濃度を減少させる方法 |
| JP2012085568A (ja) * | 2010-10-18 | 2012-05-10 | Kao Corp | ゼリー状食品 |
| US20130129680A1 (en) * | 2011-11-23 | 2013-05-23 | Thomas Christian Lines | Method for treating hepatitis c virus infection using quercetin-containing compositions |
| WO2013133408A1 (fr) * | 2012-03-09 | 2013-09-12 | 武田薬品工業株式会社 | Médicament liquide pour utilisation interne |
| WO2014070014A1 (fr) * | 2012-11-01 | 2014-05-08 | Rijksuniversiteit Groningen | Procédés et compositions pour la stimulation de bactéries bénéfiques dans le tractus gastro-intestinal |
| JP6752012B2 (ja) * | 2015-11-13 | 2020-09-09 | 太陽化学株式会社 | テルペノイド減少抑制剤 |
| CN106278991B (zh) * | 2016-08-03 | 2018-10-26 | 沅江华龙催化科技有限公司 | 一种由nhpi与含苄基化合物在非金属催化下直接偶联制备pino衍生物的方法 |
| CN106349149B (zh) * | 2016-08-03 | 2018-12-18 | 沅江华龙催化科技有限公司 | 一种由nhpi与酮类化合物直接偶联制备pino衍生物的方法 |
| CN106306887A (zh) * | 2016-08-19 | 2017-01-11 | 朱路 | 一种可以缓解婴儿吐奶不适性的植物维生素滴剂 |
| CA3121235A1 (fr) | 2018-11-30 | 2020-06-04 | Beth Israel Deaconess Medical Center, Inc. | Compositions et methodes pour reduire les evenements thrombotiques majeurs chez les patients cancereux |
| CN112021573A (zh) * | 2020-05-26 | 2020-12-04 | 上海轻姿健康管理有限公司 | 一种提高耐力的运动营养组合物 |
| WO2022131063A1 (fr) * | 2020-12-18 | 2022-06-23 | サントリーホールディングス株式会社 | Composition pour améliorer la flexibilité musculaire |
| WO2024101207A1 (fr) * | 2022-11-07 | 2024-05-16 | サントリーホールディングス株式会社 | Composition inhibant le déclin des fonctions cognitives ou les améliorant comprenant une quercétine ou un glycoside de celle-ci |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3130327B2 (ja) * | 1991-03-29 | 2001-01-31 | 日鉱金属株式会社 | 肝機能障害予防剤及び肝機能障害予防作用を有する機能性食品 |
| AT407942B (de) * | 1997-04-16 | 2001-07-25 | Husz Georg Bela | Getränk, konzentrat-kombination sowie verfahren zur herstellung eines getränkes |
| US5846569A (en) * | 1997-06-20 | 1998-12-08 | Creative Labs, Inc. | Colostrum supplement |
| WO2000012085A1 (fr) * | 1998-08-27 | 2000-03-09 | Merck Patent Gmbh | Compositions d'ascorbate-isoquercetine |
| US6261589B1 (en) * | 1999-03-02 | 2001-07-17 | Durk Pearson | Dietary supplement nutrient soft drink composition with psychoactive effect |
| US6210701B1 (en) * | 1999-04-30 | 2001-04-03 | Healthcomm International, Inc. | Medical food for treating inflammation-related diseases |
| US6299925B1 (en) * | 1999-06-29 | 2001-10-09 | Xel Herbaceuticals, Inc. | Effervescent green tea extract formulation |
| US6579544B1 (en) * | 2000-05-31 | 2003-06-17 | Nutriex, L.L.C. | Method for supplementing the diet |
| JP2002051732A (ja) * | 2000-06-12 | 2002-02-19 | Access Business Group Llc | 食事による植物性化学物質欠乏症を矯正する組成物及び方法 |
| AU2001277940A1 (en) * | 2000-07-20 | 2002-02-05 | Bradford D. Pitman | Dietary supplement compositions |
| JP4043194B2 (ja) * | 2001-02-15 | 2008-02-06 | 株式会社大貴 | 不織布及び該不織布の製造方法 |
| US20030068391A1 (en) * | 2001-10-04 | 2003-04-10 | Harris Dennis H. | Ingestible nerve and circulatory nutritional formulation |
| ES2322577T3 (es) * | 2002-10-23 | 2009-06-23 | Quercegen Holdings Llc | Composiciones antioxidantes. |
-
2003
- 2003-10-14 ES ES03774827T patent/ES2322577T3/es not_active Expired - Lifetime
- 2003-10-14 DK DK03774827T patent/DK1562447T3/da active
- 2003-10-14 KR KR1020057007030A patent/KR101186898B1/ko not_active IP Right Cessation
- 2003-10-14 AU AU2003282829A patent/AU2003282829B2/en not_active Ceased
- 2003-10-14 JP JP2004546861A patent/JP2006507283A/ja active Pending
- 2003-10-14 EP EP03774827A patent/EP1562447B1/fr not_active Expired - Lifetime
- 2003-10-14 CA CA2503363A patent/CA2503363C/fr not_active Expired - Fee Related
- 2003-10-14 AT AT03774827T patent/ATE416629T1/de active
- 2003-10-14 DE DE60325265T patent/DE60325265D1/de not_active Expired - Lifetime
- 2003-10-14 PT PT03774827T patent/PT1562447E/pt unknown
- 2003-10-20 TW TW092129007A patent/TWI337066B/zh not_active IP Right Cessation
- 2003-10-23 NZ NZ540165A patent/NZ540165A/en not_active IP Right Cessation
- 2003-10-23 PT PT03779239T patent/PT1562449E/pt unknown
- 2003-10-23 EP EP03779239A patent/EP1562449B1/fr not_active Expired - Lifetime
- 2003-10-23 DK DK03779239.7T patent/DK1562449T3/da active
- 2003-10-23 TW TW092129416A patent/TWI383753B/zh not_active IP Right Cessation
- 2003-10-23 CA CA2503373A patent/CA2503373C/fr not_active Expired - Fee Related
- 2003-10-23 AU AU2003284919A patent/AU2003284919A1/en not_active Abandoned
- 2003-10-23 AT AT03779239T patent/ATE500747T1/de active
- 2003-10-23 DE DE60336336T patent/DE60336336D1/de not_active Expired - Lifetime
- 2003-10-23 KR KR1020057007029A patent/KR20050103268A/ko not_active Application Discontinuation
- 2003-10-23 JP JP2004547143A patent/JP2006503896A/ja active Pending
-
2006
- 2006-06-14 HK HK06106781A patent/HK1086725A1/xx not_active IP Right Cessation
-
2011
- 2011-03-09 JP JP2011052092A patent/JP2011157366A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2503363A1 (fr) | 2004-05-06 |
| JP2011157366A (ja) | 2011-08-18 |
| AU2003282829B2 (en) | 2010-07-22 |
| NZ540165A (en) | 2008-10-31 |
| EP1562447B1 (fr) | 2008-12-10 |
| DE60325265D1 (de) | 2009-01-22 |
| PT1562447E (pt) | 2009-03-17 |
| EP1562447A4 (fr) | 2006-04-12 |
| EP1562449A4 (fr) | 2008-02-20 |
| TW200412863A (en) | 2004-08-01 |
| DK1562449T3 (da) | 2011-06-06 |
| EP1562449B1 (fr) | 2011-03-09 |
| AU2003282829A1 (en) | 2004-05-13 |
| TWI383753B (zh) | 2013-02-01 |
| ES2322577T3 (es) | 2009-06-23 |
| TW200409601A (en) | 2004-06-16 |
| JP2006503896A (ja) | 2006-02-02 |
| TWI337066B (en) | 2011-02-11 |
| DK1562447T3 (da) | 2009-04-06 |
| CA2503373A1 (fr) | 2004-05-06 |
| KR20050088994A (ko) | 2005-09-07 |
| KR101186898B1 (ko) | 2012-10-02 |
| EP1562447A1 (fr) | 2005-08-17 |
| CA2503373C (fr) | 2013-01-15 |
| ATE500747T1 (de) | 2011-03-15 |
| EP1562449A1 (fr) | 2005-08-17 |
| DE60336336D1 (de) | 2011-04-21 |
| ATE416629T1 (de) | 2008-12-15 |
| KR20050103268A (ko) | 2005-10-28 |
| JP2006507283A (ja) | 2006-03-02 |
| PT1562449E (pt) | 2011-06-16 |
| CA2503363C (fr) | 2012-01-17 |
| AU2003284919A1 (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1086725A1 (en) | Antioxidative compositions | |
| WO2002081651A3 (fr) | Polyphenols destines a favoriser la fibrinolyse associee aux cellules endotheliales | |
| ZA200500877B (en) | Antimicrobial aza-bicyclic derivatives, their compositions and uses. | |
| SG149857A1 (en) | Oral care compositions containing free-b-ring flavonoids and flavans | |
| HK1075617A1 (en) | Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis | |
| TW200732296A (en) | Novel compounds | |
| WO2007064885A3 (fr) | Compositions, procedes, dispositifs et systemes pour soins buccaux | |
| ZA200501082B (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| MX2008002492A (es) | Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante. | |
| TW200700071A (en) | Novel use | |
| AU2003293592A8 (en) | Novel nutraceutical compositions comprising epigallocatechin gallate | |
| DE60109632D1 (de) | Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung | |
| WO2007013901A3 (fr) | Stabilisation de couleur de composants chimiques aromatiques | |
| AU2003298659A8 (en) | Soluble isoflavone compositions | |
| TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
| WO2003013270A3 (fr) | Supplement dietetique de calcium | |
| WO2009118726A3 (fr) | Combinaison orale de vitamines | |
| WO2007075255A3 (fr) | Composition de gomme mastic utilisable en tant que complement alimentaire pour les humains et les animaux | |
| WO2003105751A3 (fr) | Nouveaux derives de curcumine | |
| ZA200501387B (en) | Antimicrobial compositions. | |
| EP1773354A4 (fr) | Compositions de vitamine b12 | |
| WO2009129926A8 (fr) | Compositions destinées au traitement et à la prévention des infections de la cavité orale | |
| WO2008070354A3 (fr) | Benzidimidazole thiophènes substitués en 5 et 6 pour plk | |
| MY151067A (en) | Oral care compositions containing flavonoids and flavans | |
| IL180777A (en) | Chromen-2- one derivatives, pharmaceutical compositions comprising them and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171014 |